These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3922532)

  • 1. Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis.
    Levin M; Holland PC; Nokes TJ; Novelli V; Mola M; Levinsky RJ; Dillon MJ; Barratt TM; Marshall WC
    Br Med J (Clin Res Ed); 1985 May; 290(6480):1456-60. PubMed ID: 3922532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet immune complex interaction in the pathogenesis of Kawasaki disease.
    Levin M; Holland PC; Novelli V
    Prog Clin Biol Res; 1987; 250():227-37. PubMed ID: 3423040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kawasaki disease: monitoring of circulating immune complexes.
    Salo E; Kekomäki R; Pelkonen P; Ruuskanen O; Viander M; Wagner O
    Eur J Pediatr; 1988 May; 147(4):377-80. PubMed ID: 3294012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of platelet aggregation by immune complexes. I. Clinical studies].
    Shkhvatsabaia IK; Osipov SG; Turlubekov KK; Titov VN; Kasatkina LV
    Biull Eksp Biol Med; 1982 Nov; 94(11):27-9. PubMed ID: 7150731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms.
    Burns JC; Glode MP; Clarke SH; Wiggins J; Hathaway WE
    J Pediatr; 1984 Aug; 105(2):206-11. PubMed ID: 6235335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease).
    Lin CY; Hwang B
    Ann Allergy; 1987 Oct; 59(4):291-7. PubMed ID: 3662131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired granulocyte chemotaxis and increased circulating immune complexes in Kawasaki disease.
    Ono S; Onimaru T; Kawakami K; Hokonohara M; Miyata K
    J Pediatr; 1985 Apr; 106(4):567-70. PubMed ID: 3981310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between mean platelet volume-to-lymphocyte ratio and coronary artery abnormalities in Kawasaki disease.
    Bozlu G; Karpuz D; Hallioglu O; Unal S; Kuyucu N
    Cardiol Young; 2018 Jun; 28(6):832-836. PubMed ID: 29656728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of thromboxane in the pathogenesis of Kawasaki disease and a suggestion for using novel thromboxane synthetase inhibitors in its treatment.
    Backon J
    Med Hypotheses; 1991 Mar; 34(3):230-1. PubMed ID: 1905778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan.
    Kuwabara M; Yashiro M; Kotani K; Tsuboi S; Ae R; Nakamura Y; Yanagawa H; Kawasaki T
    J Epidemiol; 2015; 25(3):189-93. PubMed ID: 25716055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of serum thrombopoietin precedes thrombocytosis in Kawasaki disease.
    Ishiguro A; Ishikita T; Shimbo T; Matsubara K; Baba K; Hayashi Y; Naritaka S; Nakahata T
    Thromb Haemost; 1998 Jun; 79(6):1096-100. PubMed ID: 9657430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Antioxidants in Horse Serum-mediated Vasculitis in Swine: Potential Relevance to Early Treatment in Mitigation of Coronary Arteritis in Kawasaki Disease.
    Philip S; Lee WC; Cherian KM; Wu MH; Lue HC
    Pediatr Neonatol; 2017 Aug; 58(4):328-337. PubMed ID: 28209472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet Fc receptor. Increased expression in myeloproliferative disease.
    Moore A; Nachman RL
    J Clin Invest; 1981 Apr; 67(4):1064-71. PubMed ID: 6937475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet aggregation and release associated with immune complex formation in pig plasma.
    Clark WF; Tevaarwerk GJ; Bandali K; Lindsay RM; Linton AL
    J Lab Clin Med; 1980 Oct; 96(4):654-65. PubMed ID: 7419956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of vasculitis. Lessons we can learn to improve our understanding of Kawasaki disease.
    Lehman TJ; Mahnovski V
    Rheum Dis Clin North Am; 1988 Aug; 14(2):479-87. PubMed ID: 3140306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes in Kawasaki syndrome.
    Mason WH; Jordan SC; Sakai R; Takahashi M; Bernstein B
    Pediatr Infect Dis; 1985; 4(1):48-51. PubMed ID: 3881741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of 100 patients with Kawasaki disease.
    Tizard EJ; Suzuki A; Levin M; Dillon MJ
    Arch Dis Child; 1991 Feb; 66(2):185-8. PubMed ID: 1900405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum thrombopoietin levels in Kawasaki disease.
    Miura N; Terai M; Meng YG; Sato T; Niimi H
    Br J Haematol; 1998 Feb; 100(2):387-8. PubMed ID: 9488632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human platelet-immune complex interaction in plasma.
    Clark WF; Tevaarwerk GJ; Reid BD
    J Lab Clin Med; 1982 Dec; 100(6):917-31. PubMed ID: 6982951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-aggregating immune complexes and intraplatelet serotonin in idiopathic glomerulonephritis and systemic lupus.
    Kasai N; Parbtani A; Cameron JS; Yewdall V; Shepherd P; Verroust P
    Clin Exp Immunol; 1981 Jan; 43(1):64-72. PubMed ID: 7249395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.